Publicacions en col·laboració amb investigadors/es de Dana–Farber Cancer Institute (2)

2022

  1. ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or Leptomeninges

    Clinical Cancer Research, Vol. 28, Núm. 12, pp. 2506-2516

2017

  1. Selumetinib plus docetaxel compared with docetaxel alone and progression-free survival in patients with KRAS-mutant advanced non-small cell lung cancer: The SELECT-1 randomized clinical trial

    JAMA - Journal of the American Medical Association, Vol. 317, Núm. 18, pp. 1844-1853